Search

everythinglearnresearchcommunity

for

Search:↓

Sunekos® effectively improves labia majora appearance and is well-tolerated.

Person-to-person hair transplants can work for patients on lifelong immunosuppression, with high hair growth success.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Patch testing helps find allergens in minoxidil treatments, but doesn't ensure alternatives will be tolerated.

Valproic acid effectively reduces aggressive and impulsive behaviors in brain injury patients with acceptable side effects.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Finasteride may help some male chronic pelvic pain patients, but more research needed.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Combining 5% minoxidil and 0.5% anthralin can help regrow hair in some severe alopecia areata patients.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Using minoxidil and anthralin together can improve hair regrowth in severe alopecia areata patients who didn't respond to individual treatments.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.

Modified phenol peels effectively reduced stubborn skin pigmentation in patients with Lichen Planus Pigmentosus.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Oral minoxidil helped significantly regrow hair in a patient with traction alopecia.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

TH07 effectively promotes hair regrowth in androgenic alopecia with high patient satisfaction and no major side effects.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Using lidocaine before keloid injections makes the treatment more comfortable for patients.

The wigs made from human hair and polypropylene were mostly well-tolerated and durable in rabbits, suggesting they could be a new option for people with extensive hair loss.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Both topiramate and divalproex sodium effectively reduce migraine frequency and are generally well-tolerated.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.